Euclid Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-1,800
| Closed | -$629K | – | 371 |
|
|
2016
Q2 | $629K | Sell |
1,800
-1,557
| -46% | -$544K | 0.03% | 361 |
|
|
2016
Q1 | $1.21M | Sell |
3,357
-3,534
| -51% | -$1.27M | 0.05% | 322 |
|
|
2015
Q4 | $3.74M | Buy |
+6,891
| New | +$3.74M | 0.11% | 218 |
|
|
2015
Q3 | – | Sell |
-12,375
| Closed | -$6.31M | – | 400 |
|
|
2015
Q2 | $6.31M | Sell |
12,375
-14,495
| -54% | -$7.39M | 0.12% | 215 |
|
|
2015
Q1 | $12.1M | Buy |
+26,870
| New | +$12.1M | 0.22% | 95 |
|
|
2014
Q4 | – | Sell |
-37,440
| Closed | -$13.5M | – | 475 |
|
|
2014
Q3 | $13.5M | Sell |
37,440
-710
| -2% | -$256K | 0.1% | 195 |
|
|
2014
Q2 | $10.8M | Sell |
38,150
-5,206
| -12% | -$1.47M | 0.08% | 255 |
|
|
2014
Q1 | $13M | Buy |
43,356
+12,210
| +39% | +$3.67M | 0.1% | 186 |
|
|
2013
Q4 | $8.57M | Sell |
31,146
-1,730
| -5% | -$476K | 0.07% | 257 |
|
|
2013
Q3 | $10.3M | Buy |
32,876
+7,376
| +29% | +$2.31M | 0.1% | 200 |
|
|
2013
Q2 | $5.74M | Buy |
+25,500
| New | +$5.74M | 0.07% | 272 |
|